Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice
Authors
Keywords
Heart, Glucose, Ischemia, Cell membranes, Reperfusion, Immunoblotting, Glucose metabolism, Membrane proteins
Journal
PLoS One
Volume 10, Issue 6, Pages e0130605
Publisher
Public Library of Science (PLoS)
Online
2015-06-30
DOI
10.1371/journal.pone.0130605
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tropomodulin3 is a novel Akt2 effector regulating insulin-stimulated GLUT4 exocytosis through cortical actin remodeling
- (2015) Chun-Yan Lim et al. Nature Communications
- Phlorizin Prevents Electrically-Induced Ventricular Tachyarrhythmia during Ischemia in Langendorff-Perfused Guinea-Pig Hearts
- (2014) Masamichi Hirose et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
- (2014) Bowen Lin et al. Cardiovascular Diabetology
- Arachidonate 12/15-Lipoxygenase–Induced Inflammation and Oxidative Stress Are Involved in the Development of Diabetic Cardiomyopathy
- (2014) Hirofumi Suzuki et al. DIABETES
- Preconditioning actions of aldosterone through p38 signaling modulation in isolated rat hearts
- (2014) Takuya Yoshino et al. JOURNAL OF ENDOCRINOLOGY
- Transgenic Knockdown of Cardiac Sodium/Glucose Cotransporter 1 (SGLT1) Attenuates PRKAG2 Cardiomyopathy, Whereas Transgenic Overexpression of Cardiac SGLT1 Causes Pathologic Hypertrophy and Dysfunction in Mice
- (2014) Mohun Ramratnam et al. Journal of the American Heart Association
- Transient decrease in serum potassium level during ischemic attack of acute coronary syndrome: Paradoxical contribution of plasma glucose level and glycohemoglobin
- (2013) Hiroshi Sekiyama et al. Cardiovascular Diabetology
- Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30-50% of Filtered Glucose Load in Humans
- (2013) M. A. Abdul-Ghani et al. DIABETES
- MAP17 and SGLT1 Protein Expression Levels as Prognostic Markers for Cervical Tumor Patient Survival
- (2013) Marco Perez et al. PLoS One
- An Immunohistochemical Analysis of Tissue Thrombin Expression in the Human Atria
- (2013) Keiichi Ito et al. PLoS One
- SGLT inhibitors in management of diabetes
- (2013) Abd A Tahrani et al. Lancet Diabetes & Endocrinology
- Regional distribution of SGLT activity in rat brain in vivo
- (2012) Amy S. Yu et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2
- (2012) Abhinav Kanwal et al. ANALYTICAL BIOCHEMISTRY
- The role of Na+/H+ exchanger in Ca2+ overload and ischemic myocardial damage in hearts from type 2 diabetic db/db mice
- (2012) Ryuko Anzawa et al. Cardiovascular Diabetology
- Biphasic Action of Aldosterone on Akt Signaling in Cardiomyocytes
- (2012) T. Nagoshi et al. HORMONE AND METABOLIC RESEARCH
- An enzymatic photometric assay for 2-deoxyglucose uptake in insulin-responsive tissues and 3T3-L1 adipocytes
- (2011) Kumiko Saito et al. ANALYTICAL BIOCHEMISTRY
- NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1
- (2011) Magali Balteau et al. CARDIOVASCULAR RESEARCH
- Optimization of Cardiac Metabolism in Heart Failure
- (2011) Tomohisa Nagoshi et al. CURRENT PHARMACEUTICAL DESIGN
- Na+-D-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose Absorption and Glucose-Dependent Incretin Secretion
- (2011) V. Gorboulev et al. DIABETES
- Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury
- (2011) Jun Yoshioka et al. JOURNAL OF CLINICAL INVESTIGATION
- Biology of Human Sodium Glucose Transporters
- (2011) Ernest M. Wright et al. PHYSIOLOGICAL REVIEWS
- Functional effects of glucose transporters in human ventricular myocardium
- (2010) Dirk von Lewinski et al. EUROPEAN JOURNAL OF HEART FAILURE
- SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy
- (2010) Sanjay K. Banerjee et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Glucose-transporter–mediated positive inotropic effects in human myocardium of diabetic and nondiabetic patients
- (2010) Dirk von Lewinski et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- SGLT2 inhibition — a novel strategy for diabetes treatment
- (2010) Edward C. Chao et al. NATURE REVIEWS DRUG DISCOVERY
- SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states
- (2009) S. K. Banerjee et al. CARDIOVASCULAR RESEARCH
- Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction
- (2009) Stuart A. Cook et al. EUROPEAN HEART JOURNAL
- Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
- (2008) S. Han et al. DIABETES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now